Jump to content


Congrats to Margaret, Platinum Member with 1,000 posts and 10 Years of Forums Membership!


Photo

Treatment of diffuse systemic sclerosis (dSSc) with hyperimmune caprine serum (AIMSPRO): a phase II double-blind placebo-controlled trial.


  • Please log in to reply
No replies to this topic

#1 Joelf

Joelf

    Star Ruby Member

  • ISN Root Admin
  • PipPipPipPipPipPipPipPipPipPipPipPipPip
  • 4,616 posts
  • Location:West Sussex

Posted 26 February 2014 - 01:52 PM

Treatment of diffuse systemic sclerosis (dSSc) with hyperimmune caprine serum (AIMSPRO): a phase II double-blind placebo-controlled trial.

 

These results confirm tolerability and safety of this novel biological agent in established dSSc and the value of a placebo treated control group in small clinical trials evaluating skin disease in SSc is confirmed. PubMed, Ann Rheum Dis, 2014 Jan 1;73(1):56-61. (Also see: AIMSPRO Clinical Trial, and Diffuse Scleroderma)

 

This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.


Jo Frowde
ISN Assistant Webmaster

SD World Webmaster
ISN Sclero Forums Manager
ISN News Manager

ISN Hotline Support Specialist
ISN Chat Host
International Scleroderma Network (ISN)